Crystal structures of the gastric proton pump

被引:90
|
作者
Abe, Kazuhiro [1 ,2 ,3 ]
Irie, Katsumasa [1 ,2 ]
Nakanishi, Hanayo [1 ,3 ]
Suzuki, Hiroshi [4 ]
Fujiyoshi, Yoshinori [1 ,3 ,5 ]
机构
[1] Nagoya Univ, Cellular & Struct Physiol Inst, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan
[3] Japan Sci & Technol Corp, Japan Core Res Evolut Sci & Technol, Nagoya, Aichi, Japan
[4] Rockefeller Univ, Lab Mol Electron Microscopy, 1230 York Ave, New York, NY 10021 USA
[5] CeSPIA Inc, Tokyo, Japan
关键词
ADP-INSENSITIVE PHOSPHOENZYME; K+-BINDING-SITE; ION-TRANSPORT; SALT BRIDGE; ATPASE; H+; K+-ATPASE; MECHANISM; ACID; NA; K-ATPASE; CA2+-ATPASE;
D O I
10.1038/s41586-018-0003-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The gastric proton pump-the H+, K+-ATPase-is a P-type ATPase responsible for acidifying the gastric juice down to pH 1. This corresponds to a million-fold proton gradient across the membrane of the parietal cell, the steepest known cation gradient of any mammalian tissue. The H+, K+-ATPase is an important target for drugs that treat gastric acid-related diseases. Here we present crystal structures of the H+, K+-ATPase in complex with two blockers, vonoprazan and SCH28080, in the luminal-open state, at 2.8 angstrom resolution. The drugs have partially overlapping but clearly distinct binding modes in the middle of a conduit running from the gastric lumen to the cation-binding site. The crystal structures suggest that the tight configuration at the cation-binding site lowers the pK(a) value of Glu820 sufficiently to enable the release of a proton even into the pH 1 environment of the stomach.
引用
收藏
页码:214 / +
页数:16
相关论文
共 50 条
  • [31] Gastric carcinoids - A temporal increase with proton pump introduction
    Hodgson, N
    Koniaris, LG
    Livingstone, AS
    Franceschi, D
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2005, 19 (12): : 1610 - 1612
  • [32] Are Proton Pump Inhibitors a Risk Factor for Gastric Cancer?
    Boo, Sun-Jin
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2022, 79 (01): : 49 - 51
  • [33] MECHANISM OF GASTRIC PROTON PUMP INHIBITION BY VERAPAMIL (V)
    NANDI, J
    KING, RL
    LEVINE, RA
    FASEB JOURNAL, 1988, 2 (04): : A718 - A718
  • [34] Association of gastric polyps with proton pump inhibitor therapy
    Moore, AL
    Poh, CH
    McFarland, RJ
    Tham, TCK
    GUT, 2001, 48 : A37 - A37
  • [35] Structure-function study on gastric proton pump
    Asano, S
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1997, 117 (07): : 379 - 393
  • [36] Proton pump inhibitor: The dual role in gastric cancer
    Moon Kyung Joo
    Jong-Jae Park
    Hoon Jai Chun
    World Journal of Gastroenterology, 2019, 25 (17) : 2058 - 2070
  • [37] Use of Proton Pump Inhibitors and risk of gastric cancer
    Karakan, Tarkan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2018, 29 (01): : 143 - 144
  • [38] Proton pump inhibitor: The dual role in gastric cancer
    Joo, Moon Kyung
    Park, Jong-Jae
    Chun, Hoon Jai
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (17) : 2058 - 2070
  • [39] Gastric polyposis due to treatment with proton pump inhibitors
    Maria Huguet, Jose
    Ruiz, Lucia
    Orti, Elisa
    Lujan, Marisol
    Sempere, Javier
    Medina, Enrique
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2009, 32 (02): : 88 - 91
  • [40] Effects of proton pump inhibitors on gastric corpus mucosa
    Acar, K.
    Doganavsargil, B.
    Sezak, M.
    Bor, S.
    VIRCHOWS ARCHIV, 2014, 465 : S154 - S154